High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses
2012; Springer Nature; Volume: 26; Issue: 11 Linguagem: Inglês
10.1038/leu.2012.105
ISSN1476-5551
AutoresStephan Metzelder, Thomas Schroeder, Anemone Finck, Sebastian Scholl, Martin F. Fey, Katharina S. Götze, Yeh Ching Linn, M. Kröger, Andreas Reiter, Helmut R. Salih, Thomas Heinicke, Reingard Stuhlmann, Lutz Müller, Aristoteles Giagounidis, Ralf G. Meyer, Wolfram Brugger, Matthias Vöhringer, Peter Dreger, Masanori Mori, Nadežda Basara, K. Schäfer-Eckart, Beate Schultheis, Claudia D. Baldus, Andreas Neubauer, Andreas Burchert,
Tópico(s)Myeloproliferative Neoplasms: Diagnosis and Treatment
Referência(s)